drugset / Trial / NCT01117649

Plasma Volume Replacement (PVR) Therapy With Colloid and Crystalloid Solutions

NCT01117649 ↗

Phase 4 Completed 63 enrolled B. Braun Melsungen AG
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to investigate the efficacy of target controlled fluid therapy with a hyper-oncotic balanced HES solution compared to an iso-oncotic HES solution in patients undergoing elective surgery of the pancreatic head. A third group receiving a balanced electrolyte solution (without colloidal volume replacement) will serve as a control for descriptive analysis.

Timeline

Start
2010-05
Primary completion
2012-07
Completion
2013-07

Drugs

EvaluationDrugModalityDoseRoute
Subject HES Unknown 6 % —
Subject HES Unknown 10 % —
Comparator balanced electrolyte solution Unknown — —

Indications